ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2011

Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER-) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors.

Karina A Galoian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.